Calcineurin subunit B activates dendritic cells and acts as a cancer vaccine adjuvant

Author： Li Jing Guo JunXia Su ZhenYi Hu MinLing Liu Wei Wei Qun

ISSN： 1460-2377

Source： International Immunology, Vol.23, Iss.5, 2011-05, pp. : 327-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IL-2 mediates adjuvant effect of dendritic cells

By Granucci F. Andrews D.M. Degli-Esposti M.A. Ricciardi-Castagnoli P.

Trends in Immunology, Vol. 23, Iss. 4, 2002-04 ,pp. : 169-171

Elsevier

Access to resources Recommend Favorite

Dendritic cells in cancer vaccines

By Brossart P. Wirths S. Brugger W. Kanz L.

Experimental Hematology, Vol. 29, Iss. 11, 2001-11 ,pp. : 1247-1255

Elsevier

Access to resources Recommend Favorite

A self-hsp60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial hsp60-specific T cells: a possible mechanism for inhibitory T cell regulation of adjuvant arthritis?

By Taams L.S.

International Immunology, Vol. 12, Iss. 7, 2000-07 ,pp. : 1041-1050

Oxford University Press

Access to resources Recommend Favorite

Targeting antigen to CD19 on B cells efficiently activates T cells

By Yan Jun

International Immunology, Vol. 17, Iss. 7, 2005-07 ,pp. : 869-877

Oxford University Press

Access to resources Recommend Favorite

Immunemaximizing (IMAX) therapy for cancer: Combination of dendritic cell vaccine and intensitymodulated radiation

Molecular and Clinical Oncology, Vol. 1, Iss. 4, 2013-01 ,pp. : 649-654

Spandidos Publications

Access to resources Recommend Favorite